Truist Securities Downgrades Translate Bio (TBIO) to Hold
Tweet
Share
E-mailGet Alerts TBIO Hot Sheet
Price: $19.23 --0%
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 12 | New: 56
Rating Summary:
9 Buy, 2 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 12 | New: 56
Trade Now!
Join SI Premium – FREE
Truist Securities analyst Joon Lee downgraded Translate Bio (NASDAQ: TBIO) from Buy to Hold with a price target of $20.00 (from $40.00).
For an analyst ratings summary and ratings history on Translate Bio click here. For more ratings news on Translate Bio click here.
Shares of Translate Bio closed at $25.70 yesterday.
You May Also Be Interested In
- Mesa Air Group (MESA) PT Raised to $14 at Raymond James Despite Storms and Power Outages
- Canaccord Genuity Upgrades CanWel Building Materials (CWX:CN) (CWXZF) to Buy
- UPDATE: Janney Downgrades Sterling Bancorp (STL) to Neutral
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
